Boyd Consultants

Boyds is a specialized, service-based consultancy operating in the digital health sector, focusing on the regulatory and strategic complexities of drug development. With over two decades of experience, the firm provides end-to-end support across all development modalities, including small molecules, biologics, and cell and gene therapies, for clients worldwide. Its business model is built on deep regulatory expertise and strategic partnerships, helping innovators navigate the path from discovery to market approval. The company is privately held and appears to be in a revenue-generating stage, supported by a high client satisfaction rate and a growing team of experts.

Integrated drug development consultancy service model, leveraging deep regulatory, clinical, and strategic expertise across all therapeutic modalities (small molecules, biologics, cell & gene therapies). No proprietary technology platform.

Competes with other specialized regulatory and drug development consultancies, as well as the service arms of large global Contract Research Organizations (CROs). Differentiation is achieved through deep, hands-on expertise in advanced therapies, a strong track record of approvals, and an integrated, expert-led service model.